Mergers & Acquisitions ·
Silo Pharma acquires software and IP from Norsight Consulting, issuing warrant for up to 300,000 shares at $1.51 exercise price
SILOSilo Pharma, Inc.
On October 1, 2026, Silo Pharma, Inc. entered into an asset purchase agreement with Norsight Consulting Inc. to acquire certain software, technology, and related intellectual property. In consideration for these assets, the Company issued a warrant to purchase up to 300,000 shares of its common stock at an exercise price of $1.51 per share. The warrant includes a cashless exercise feature, is exercisable beginning April 1, 2027, and expires on September 30, 2031. The transaction involved unregistered sales of equity securities relied upon under Section 4(a)(2) of the Securities Act. Silo Pharma, Inc. operates in the pharmaceutical industry.